|
Monday, March 22 — 8:00 AM — Salon 3 & Balconies
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section C - Breast Pathology
Chaired By: Daniel Visscher and Mamatha Chivukula
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Needle Core Biopsy Has High Sensitivity for Identifying Breast Papillary Lesions Requiring Surgical Excision: Diagnostic Accuracy in 161 Cases
(190)
LJ Elavathil, K Onuma, F Mothafar, N Akhtar-Danesh, K Dhamanaskar, A Lytwyn. - McMaster University, Hamilton, ON, Canada.
|  Add |
| 8:15 |
Non-atypical Papillary Lesions on Core Biopsy: do all of them require Surgical excision?: A Meta-analysis of 604 Cases
(228)
D Jaggessarsingh, M Singh, J Liu, P Fisher, C Tornos. - Stony Brook University Medical Center, Stony Brook, NY.
| Add |
| 8:30 |
Type and Grade of Lobular Neoplasia in Breast Core Biopsy: Does It Matter for the Clinician?
(199)
A Ghassan, WM Hanna, M Mashhour, S Nofech-Mozes, H Kahn, M Xu, J Zubovits, RS Saad. - Sunnybrook Health Sciences Center/University of Toronto, Toronto, ON, Canada.
| Add |
| 8:45 |
Distinction of Pleomorphic from Classical Lobular Carcinoma In Situ: Proposition for a Minimum Diagnostic Criteria Based on Morphology
(216)
BC Ho, AH Lee, IO Ellis. - Nottingham City Hospital, Nottingham, United Kingdom.
| Add |
| 9:00 |
Clinicopathologic Characteristics of Carcinomas That Develop after a Biopsy Containing Columnar Cell Lesions
(314)
JF Simpson, FI Boulos, WD Dupont, DL Page, ME Sanders. - Vanderbilt University Medical Center, Nashville, TN; American University, Beirut, Lebanon.
| Add |
| 9:15 |
Columnar Cell Lesions and Subsequent Breast Cancer Risk: Results from the Nurses' Health Studies
(177)
LC Collins, SA Aroner, JC Connolly, GA Colditz, SJ Schnitt, RM Tamimi. - Beth Israel Deaconess Medical Center, Boston; Harvard School of Public Health, Boston; Washington University School of Medicine, St. Louis; Harvard Medical School, Boston.
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Continued observation of the Natural History of low-grade Ductal Carcinoma In Situ in Women Treated by Biopsy only reaffirms proclivity for Local recurrence in the original site over more than 30 Years long-term Follow-Up
(307)
ME Sanders, PA Schuyler, JF Simpson, WD Dupont, DL Page. - Vanderbilt University, Nashville, TN.
| Add |
| 11:15 |
Prognostic Markers and Long-term Outcomes in Ductal Carcinoma In Situ of the Breast Treated with Excision Alone
(219)
PJ Holmes, GF Schwartz, I Chervoneva, E Pequignot, J Lloyd, DB Cornfield, JP Palazzo. - Thomas Jefferson University Hospital, Philadelphia, PA; Thomas Jefferson University, Philadelphia, PA; UPMC Presbyterian, Pittsburgh, PA; Health Network Laboratories, Allentown, PA.
| Add |
| 11:30 |
Stromal CD10 and SPARC Expression Predict recurrence of Ductal Carcinoma in Situ
(297)
W Rizzo, S Kadakia, I Chervoneva, K Nguyen, M Potoczek, S Peiper, G Schwartz, A Witkiewicz. - Thomas Jefferson University Hospital, Philadelphia, PA.
| Add |
| 11:45 |
Outcome of Women with Ductal Carcinoma In Situ (DCIS) and Concurrent Lobular Neoplasia Treated with Breast Conserving Therapy: A Case-Control Study of 657 Patients from the Cancer Research Network
(176)
LC Collins, SJ Schnitt, N Achacoso, R Haque, L Nekhlyudov, S Fletcher, C Quesenberry, L Habel. - Beth Israel Deaconess Medical Center, Boston; Kaiser Permanente Northern California, San Francisco; Kaiser Permanente Southern California, Los Angeles; Harvard Pilgrim Health Care, Boston.
| Add |
|
|
